Details for New Drug Application (NDA): 207503
✉ Email this page to a colleague
The generic ingredient in ACETAZOLAMIDE is acetazolamide sodium. There are ten drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the acetazolamide sodium profile page.
Summary for 207503
Tradename: | ACETAZOLAMIDE |
Applicant: | Breckenridge |
Ingredient: | acetazolamide |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 207503
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 125MG | ||||
Approval Date: | Apr 30, 2020 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 250MG | ||||
Approval Date: | Apr 30, 2020 | TE: | RLD: | No |
Complete Access Available with Subscription